Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Senescent cell expressing natural killer group 2 member D ligand
- Molecular classification
- Ligand
01
Overview
Senescent cells expressing natural killer group 2 member D (NKG2D) ligands are a key target for immune surveillance, particularly by natural killer (NK) cells and certain T cell subsets. These ligands, including MICA, MICB, and ULBPs, act as "distress signals" on the surface of stressed, damaged, or senescent cells, marking them for recognition and elimination by the immune system via NKG2D receptor engagement. This pathway plays critical roles in tumor immunosurveillance, antiviral immunity, and clearance of potentially deleterious senescent cell populations. Modulation of this pathway holds promise for cancer therapy and senolytic approaches targeting aging tissues.
02
Mechanism of action
NKG2D receptor activation on NK cells and T cell subsets leading to cytotoxicity
03
Biological functions
Immune surveillanceCellular stress responseTarget for NK cell-mediated cytotoxicitySenescence marker
04
Disease associations
CancerViral infectionAge-related diseases
05
Safety considerations
Potential for off-target effects due to ligand expression in healthy tissuesImmune-related adverse eventsTumor evasion through ligand shedding or downregulation
06
Biomarkers
MICAMICBULBP1ULBP2ULBP3ULBP4ULBP5ULBP6Rae-1H60Mult1
Beyond the preview
Go deeper on Senescent cell expressing natural killer group 2 member D ligand.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Senescent cell expressing natural killer group 2 member D ligand.